These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336 [Abstract] [Full Text] [Related]
3. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H, Lu D, Shu Y, Shi W, Lu S, Wang K. Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954 [Abstract] [Full Text] [Related]
4. Multidrug resistance-associated biomarkers PGP, GST-pi, Topo-II and LRP as prognostic factors in primary ovarian carcinoma. Lu D, Shi HC, Wang ZX, Gu XW, Zeng YJ. Br J Biomed Sci; 2011 May; 68(2):69-74. PubMed ID: 21706917 [Abstract] [Full Text] [Related]
5. P-Gp and TOPO II Expression and Their Clinical Significance in Colon Cancer. Dang Y, Liu F, Zhao Y. Ann Clin Lab Sci; 2020 Sep; 50(5):584-590. PubMed ID: 33067204 [Abstract] [Full Text] [Related]
6. Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors. Tews DS, Nissen A, Külgen C, Gaumann AK. J Neurooncol; 2000 Dec; 50(3):227-37. PubMed ID: 11263502 [Abstract] [Full Text] [Related]
8. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. den Boer ML, Pieters R, Kazemier KM, Rottier MM, Zwaan CM, Kaspers GJ, Janka-Schaub G, Henze G, Creutzig U, Scheper RJ, Veerman AJ. Blood; 1998 Mar 15; 91(6):2092-8. PubMed ID: 9490695 [Abstract] [Full Text] [Related]
11. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma]. Yu DQ, Yi YF. Ai Zheng; 2003 May 15; 22(5):496-9. PubMed ID: 12753710 [Abstract] [Full Text] [Related]
12. Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer. Kreisholt J, Sorensen M, Jensen PB, Nielsen BS, Andersen CB, Sehested M. Br J Cancer; 1998 May 15; 77(9):1469-73. PubMed ID: 9652763 [Abstract] [Full Text] [Related]
13. Glutathione S-transferase and P-glycoprotein expressions in neuroblastoma. Kutlik MT, Ayhan A, Göğüş S, Yalçin B, Cağlar M, Büyükpamukçu M. Pediatr Hematol Oncol; 2002 May 15; 19(5):337-45. PubMed ID: 12078865 [Abstract] [Full Text] [Related]
14. Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42. Moran E, Cleary I, Larkin AM, Amhlaoibh RN, Masterson A, Scheper RJ, Izquierdo MA, Center M, O'Sullivan F, Clynes M. Eur J Cancer; 1997 Apr 15; 33(4):652-60. PubMed ID: 9274450 [Abstract] [Full Text] [Related]
15. Caveolin-1 affects tumor drug resistance in esophageal squamous cell carcinoma by regulating expressions of P-gp and MRP1. Zhang S, Cao W, Yue M, Zheng N, Hu T, Yang S, Dong Z, Lu S, Mo S. Tumour Biol; 2016 Jul 15; 37(7):9189-96. PubMed ID: 26768616 [Abstract] [Full Text] [Related]
16. [Expression and significance of P-glycoprotein, glutathione S-transferase-pi and Topoisomerase II in gastric carcinomas]. Qin F, Qin X, Zhang X, Jia HW. Ai Zheng; 2002 Feb 15; 21(2):167-70. PubMed ID: 12479068 [Abstract] [Full Text] [Related]